GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) » Definitions » Interest Received

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Interest Received : Rp38,757 Mil (TTM As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk Interest Received?

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Interest Received for the three months ended in Sep. 2024 was Rp7,021 Mil.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Interest Received for the trailing twelve months (TTM) ended in Sep. 2024 was Rp38,757 Mil.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Interest Received Historical Data

The historical data trend for PT Industri Jamu dan Farmasi Sido Muncul Tbk's Interest Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Interest Received Chart

PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Received
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49,064.00 51,002.00 37,630.00 27,562.00 29,370.00

PT Industri Jamu dan Farmasi Sido Muncul Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Received Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,914.00 9,099.00 10,994.00 11,643.00 7,021.00

PT Industri Jamu dan Farmasi Sido Muncul Tbk Interest Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Received represents interest received by the company in the direct cash flow method.

Interest Received for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp38,757 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Interest Received Related Terms

Thank you for viewing the detailed overview of PT Industri Jamu dan Farmasi Sido Muncul Tbk's Interest Received provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Gajahmada No. 123, 1st Floor, Gedung Hotel Tentrem, Office Sido Muncul, Lantai 1, Semarang, IDN, 50134
PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Headlines

No Headlines